Prehabilitation for Hepatopancreatobiliary Surgical Patients: Interim Analysis Demonstrates a Protective Effect From Neoadjuvant Chemotherapy and Improvement in the Frailty Phenotype
Restricted accessResearch articleFirst published online May, 2021
Prehabilitation for Hepatopancreatobiliary Surgical Patients: Interim Analysis Demonstrates a Protective Effect From Neoadjuvant Chemotherapy and Improvement in the Frailty Phenotype
Prehabilitation encompasses multidisciplinary interventions to improve health and lessen incidence of surgical deterioration by reducing physiologic stress and functional decline. This study presents an interim analysis to demonstrate prehabilitation for hepatopancreatobiliary (HPB) surgical patients.
Methods
In 2018, a structured prehabilitation pilot program was implemented. Eligibility required HPB malignancy, neoadjuvant chemotherapy, and residence within hour drive. Patients were enrolled into the 4-month program. The fitness component was composed of timed up and go test and grip strength with exercise recommendations. Nutrition involved evaluation of sarcopenic obesity, glucose management, and smoking and alcohol counseling. Psychological services included psychosocial assessments and advanced care planning, with social work referrals. Component were evaluated monthly by a physician using laboratory results, nutritional data and questionnaires, psychological assessments, and validated fitness tests. Nurse navigators spoke with patients weekly to monitor compliance.
Results
At 12 months, nineteen patients were enrolled. Ten completed prehabilitation, neoadjuvant chemotherapy and underwent their surgical procedure. There were no differences found after prehabilitation in functional status, physical performance, psychosocial assessments, or nutrition. Frailty, as assessed by Fried frailty criteria, improved significantly after prehabilitation (P < .0001). Symptom severity and laboratory values did not change. Length of stay was 6.5 days and all patients were discharged to home. There was 1 readmission for transient ischemic attack and 90-day mortality rate was 0%.
Discussion
Prehabilitation to improve recovery is a promising concept encompassing a wide array of multidisciplinary assessments and interventions. It may demonstrate a protective effect on physiologic decline from chemotherapy and may reverse frailty phenotypes.
NHowladerAMNooneMKrapcho, et al. eds, SEER Cancer Statistics Review, 1975-2013. Bethesda, MD: National Cancer Institute; 2016.
2.
HundalRShafferEA. Gallbladder cancer: Epidemiology and outcome.Clin Epidemiol. 2014;6:99-109.
3.
SahaSKZhuAXFuchsCSBrooksGA. Forty‐year trends in cholangiocarcinoma incidence in the US: Intrahepatic disease on the rise.Oncol. 2016;21(5):594-599.
4.
StojadinovicAHoosABrennanMFConlonKCP. Randomized clinical trials in pancreatic cancer.Surg Oncol Clin N Am. 2002;11(1):207-229.
5.
FongYGonenMRubinDRadzynerMBrennanMF. Long-term survival is superior after resection for cancer in high-volume centers.Ann Surg. 2005;242(4):540-547; discussion 544-547.
6.
ConlonKCKlimstraDSBrennanMF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma.Ann Surg. 1996;223(3):273-279.
7.
CristDWSitzmannJVCameronJL. Improved hospital morbidity, mortality, and survival after the Whipple procedure.Ann Surg. 1987;206(3):358-365.
8.
Courtin-TanguyLTurriniOBergeatD, et al.Multicentre study of the impact of factors that may affect long-term survival following pancreaticoduodenectomy for distal cholangiocarcinoma.HPB. 2018;20(5):405-410.
9.
RichterANiedergethmannMSturmJWLorenzDPostSTredeM. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.World J Surg. 2003;27(3):324-329.
10.
SchmidtCMPowellESYiannoutsosCT, et al.Pancreaticoduodenectomy.Arch Surg. 2004;139(7):718-725; discussion 725-727.
11.
SohnTYeoCCameronJ, et al.Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators.J Gastrointest Surg. 2000;4(6):567-579.
12.
RiallTNealonWGoodwinJ, et al.Pancreatic cancer in the general population: Improvements in survival over the last decade.J Gastrointest Surg. 2006;10(9):1212-1224; discussion 1223-1224.
13.
LiebermanMDKilburnHLindseyMBrennanMF. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy.Ann Surg. 1995;222(5):638-645.
14.
GirgisMDZenatiMSKingJC, et al.Oncologic outcomes after robotic pancreatic resections are not inferior to open surgery.Ann Surg. 2019. Online ahead of print.
15.
NarayananSMartinANTurrentineFEBauerTWAdamsRBZaydfudimVM. Mortality after pancreaticoduodenectomy: Assessing early and late causes of patient death.J Surg Res. 2018;231:304-308.
16.
NarendraABaadePDAitkenJF, et al.Pancreaticoduodenectomy in a low-resection volume region: A population-level study examining the impact of hospital-volume on surgical quality and longer-term survival. HPB. 2019;22:1288-1294.
17.
NassourIWintersSBHoehnR, et al.Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma. J Surg Oncol. 2020;122:234-242.
18.
BilimoriaKYBentremDJKoCYStewartAKWinchesterDPTalamontiMS. National failure to operate on early stage pancreatic cancer.Ann Surg. 2007;246(2):173-180.
19.
BalducciL. Epidemiology of cancer and aging.J Oncol Manag. 2005;14(2):47-50.
20.
HidalgoM. Pancreatic cancer. N Engl J Med. 2010;362(17):1605-1617.
21.
FongYCohenAMFortnerJG, et al.Liver resection for colorectal metastases.J Clin Oncol, 1997;15(3):938-946.
22.
ReddySKBarbasASTurleyRSGamblinTCGellerDAMarshJW, et al.Major liver resection in elderly patients: A multi-institutional analysis.J Am Coll Surg. 2011;212(5):787-795.
23.
AdamRFrillingAEliasD, et al.Liver resection of colorectal metastases in elderly patients. Br J Surg. 2010;97(3):366-376.
24.
KatzMHWangHFlemingJB, et al.Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16(4):836-847.
25.
DeyleSBanzVMWagnerM, et al.Estimation of physiologic ability and surgical stress score does not predict immediate outcome after pancreatic surgery.Pancreas. 2011;40(5):723-729.
26.
HashimotoDTakamoriHSakamotoYTanakaHHirotaMBabaH. Can the physiologic ability and surgical stress (E-PASS) scoring system predict operative morbidity after distal pancreatectomy?Surg Today. 2010;40(7):632-637.
27.
WagnerDDeMarcoMMAminiN, et al.Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgery.World J Gastrointest Surg. 2016;8(1):27-40.
28.
HarimotoNShirabeKYamashitaY-I, et al.Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.Br J Surg. 2013;100(11):1523-1530.
29.
ValeroV3rdAminiNSpolveratoG, et al.Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg. 2015;19(2):272-281.
30.
PengPHyderOFiroozmandA, et al.Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma.J Gastrointest Surg. 2012;16(8):1478-1486.
31.
PamoukdjianFBouilletTLévyVSoussanMZelekLPaillaudE. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review. Clinical Nutrition. 2018;37(4):1101-1113.
32.
CleggAYoungJIliffeSRikkertMORockwoodK. Frailty in elderly people. Lancet. 2013;381(9868):752-762.
33.
AryaSKimSIDuwayriY, et al.Frailty increases the risk of 30-day mortality, morbidity, and failure to rescue after elective abdominal aortic aneurysm repair independent of age and comorbidities. J Vasc Surg. 2015;61(2):324-331.
34.
AsemotaAOGalliaGL. Impact of frailty on short-term outcomes in patients undergoing transsphenoidal pituitary surgery.J Neurosurg. 2019;132:360-370.
35.
DanaFCapitánDUbréMHervásARiscoRMartínez-PallíG. Physical activity and frailty as indicators of cardiorespiratory reserve and predictors of surgical prognosis: General and digestive surgery population characterization. Rev Esp Anestesiol Reanim. 2018;65(1):5-12.
36.
IsharwalSJohanningJMDwyerJGSchimidKKLaGrangeCA. Preoperative frailty predicts postoperative complications and mortality in urology patients.World J Urol. 2017;35(1):21-26.
37.
RobinsonTNWuDSPointerLDunnCLClevelandJCMossM. Simple frailty score predicts postoperative complications across surgical specialties. Am J Surg. 2013;206(4):544-550.
38.
TanK-YKawamuraYJTokomitsuATangT. Assessment for frailty is useful for predicting morbidity in elderly patients undergoing colorectal cancer resection whose comorbidities are already optimized. Am J Surg. 2012;204(2):139-143.
39.
DaleWHemmerichJKammA, et al.Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy.Ann Surg. 2014;259(5):960-965.
40.
WalstonJButaBXueQ-L. Frailty screening and interventions. Clin Geriatr Med. 2018;34(1):25-38.
41.
Santa MinaDClarkeHRitvoP, et al.Effect of total-body prehabilitation on postoperative outcomes: A systematic review and meta-analysis.Physiotherapy. 2014;100(3):196-207.
42.
HughesMJHackneyRJLambPJWigmoreSJChristopher DeansDASkipworthRJE. Prehabilitation before major abdominal surgery: A systematic review and meta-analysis. World J Surg. 2019;43(7):1661-1668.
43.
GurlitSGogolM. Prehabilitation is better than cure. Curr Opin Anaesthesiol. 2019;32(1):108-115.
44.
ChoHYoshikawaTObaMS, et al.Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: The adjuvant exercise for general elective surgery (AEGES) study group. Ann Surg Oncol. 2014;21(6):2044-2050.
45.
DronkersJLambertsHReutelingspergerI, et al.Preoperative therapeutic programme for elderly patients scheduled for elective abdominal oncological surgery: A randomized controlled pilot study. Clin Rehabil. 2010;24(7):614-622.
46.
GillisCLiCLeeL, et al.Prehabilitation versus rehabilitation. Anesthesiology. 2014;121(5):937-947.
47.
SawatzkyJ-AVKehlerDSReadyAE, et al.Prehabilitation program for elective coronary artery bypass graft surgery patients: A pilot randomized controlled study. Clin Rehabil. 2014;28(7):648-657.
48.
WestMALoughneyLLythgoeD, et al.Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: A blinded interventional pilot study. Br J Anaesth. 2015;114(2):244-251.
49.
MazzolaMBertoglioCBoniardiM, et al.Frailty in major oncologic surgery of upper gastrointestinal tract: How to improve postoperative outcomes. Eur J Surg Oncol. 2017;43(8):1566-1571.
50.
WaiteIDeshpandeRBaghaiM, et al.Home-based preoperative rehabilitation (prehab) to improve physical function and reduce hospital length of stay for frail patients undergoing coronary artery bypass graft and valve surgery. J Cardiothorac Surg. 2017;12(1):91.
51.
BrueraEKuehnNMillerMJSelmserPMacmillanK. The edmonton symptom assessment system (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6-9.
52.
KarnofskyDABurchenalJH. The clinical evaluation of chemotherapeutic agents in cancer. In: CMMacLeod, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949:191-205.
53.
KatzSDownsTDCashHRGrotzRC. Progress in development of the index of ADL. Gerontol. 1970;10(1):20-30.
54.
LawtonMPBrodyEM. Assessment of older people: Self-maintaining and instrumental activities of daily living.Gerontol. 1969;9(3):179-186.
55.
PodsiadloDRichardsonS. The timed “up & go”: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142-148.
56.
Sousa-SantosARAmaralTF. Differences in handgrip strength protocols to identify sarcopenia and frailty - A systematic review. BMC Geriatr. 2017;17(1):238.
57.
CharlsonMSzatrowskiTPPetersonJGoldJ. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-1251.
58.
HobsonJ. The Montreal cognitive assessment (MoCA). Occup Med. 2015;65(9):764-765.
59.
ArrollBGoodyear-SmithFCrengleS, et al.Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348-353.
60.
WilliamsN. The CAGE questionnaire.Occup Med. 2014;64(6):473-474.
61.
American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227-2246.
62.
FriedLPTangenCMWalstonJ, et al.Frailty in older adults: Evidence for a phenotype.J Gerontol Series A: Biol Sci Med Sci. 2001;56(3):M146-M157.
63.
VellasBGuigozYGarryPJ, et al.The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;15(2):116-122.
64.
Ngo-HuangAHolmesHMdes BordesJKA, et al.Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma. Cancer Medicine. 2019;8(6):2867-2876.
65.
SinghFNewtonRUGalvãoDASpryNBakerMK. A systematic review of pre-surgical exercise intervention studies with cancer patients. Surgical Oncology. 2013;22(2):92-104.
66.
LoughneyLWestMAKempGJGrocottMPWJackS. Exercise intervention in people with cancer undergoing neoadjuvant cancer treatment and surgery: A systematic review.Eur J Surg Oncol. 2016;42(1):28-38.
67.
KhoranaAAManguPBBerlinJ, et al.Potentially curable pancreatic cancer: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2016;34(21):2541-2556.
68.
CooperABSlackRFogelmanD, et al.Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer. Ann Surg Oncol. 2015;22(7):2416-2423.
69.
DalyLENí BhuachallaÉBPowerDGCushenSJJamesKRyanAM. Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer. J Cachexia, Sarcopenia Muscle. 2018;9(2):315-325.
70.
ErikssonSNilssonJHStrandberg HolkaPEberhardJKeussenISturessonC. The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases. HPB. 2017;19(4):331-337.
71.
GriffinOMDugganSNRyanRMcDermottRGeogheganJConlonKC. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer. Pancreatology. 2019;19(6):850-857.
72.
DunneDFJJackSJonesRP, et al.Randomized clinical trial of prehabilitation before planned liver resection. Br J Surg. 2016;103(5):504-512.
73.
Ngo-HuangAParkerNHWangX, et al.Home-based exercise during preoperative therapy for pancreatic cancer. Langenbeck’s Arch Surg. 2017;402(8):1175-1185.
74.
ValkenetKvan de PortIGDronkersJJde VriesWRLindemanEBackxFJ. The effects of preoperative exercise therapy on postoperative outcome: A systematic review. Clin Rehabil. 2011;25(2):99-111.
BrownMSinacoreDREhsaniAABinderEFHolloszyJOKohrtWM. Low-intensity exercise as a modifier of physical frailty in older adults. Arch Phys Med Rehabil. 2000;81(7):960-965.
77.
TraversJRomero-OrtunoRBaileyJCooneyM-T. Delaying and reversing frailty: A systematic review of primary care interventions. Br J Gen Pract. 2019;69(678):e61-e69.
78.
AugustinTBursteinMDSchneiderEB, et al.Frailty predicts risk of life-threatening complications and mortality after pancreatic resections.Surgery. 2016;160(4):987-996.
79.
GuytonRLJrMosqueraCSpaniolasKFitzgeraldTL. Association of increasing frailty with detrimental outcomes after pancreatic resection. Am Surg. 2018;84(4):512-519.
80.
MalgrasBDuronSGaujouxS, et al.Early biliary complications following pancreaticoduodenectomy: Prevalence and risk factors.HPB. 2016;18(4):367-374.
